Kim Sunghoon, Kang Junghee, Evers B Mark, Chung Dai H
Department of Surgery, The University of Texas Medical Branch, Galveston, TX 77555-0353, USA.
J Pediatr Surg. 2004 Apr;39(4):509-15. doi: 10.1016/j.jpedsurg.2003.12.009.
The expression of caspase-8, a cysteine protease that is crucial for the apoptotic cascade, is absent in a high percentage of neuroblastomas, the most frequent extracranial solid tumor of infants and children. Resistance of neuroblastomas to death-receptor (eg, tumor necrosis factor alpha (TNF-alpha) receptor)--mediated apoptosis is thought to be caused by loss of caspase-8 expression. Gene silencing by hypermethylation of caspase-8 promoter has been proposed for the loss of caspase-8 expression in neuroblastoma cells.
To further evaluate the role of caspase-8 in neuroblastoma, we assessed the induction of caspase-8 expression in neuroblastoma cells by treating the cells with a physiologic agent such as interferon-gamma.
The authors found that interferon-gamma induces caspase-8 expression in neuroblastoma cells irrespective of the gene silenced by hypermethylation of caspase-8 promoter. The authors show that interferon-gamma also regulates other apoptosis related gene expression. Moreover, they show that interferon-gamma treatment in combination with TNF-alpha decreases neuroblastoma cell proliferation.
Interferon-gamma induces procaspase-8 expression in neuroblastoma cells, and this induction is not dependent on demethylation of the caspase-8 promoter. Therapies aimed at inducing caspase-8 expression by adjunctive treatment, such as interferon-gamma, may increase the effectiveness of current chemotherapeutic regimens.